Literature DB >> 11509915

Changes in Thy1 gene expression associated with damaged retinal ganglion cells.

C L Schlamp1, E C Johnson, Y Li, J C Morrison, R W Nickells.   

Abstract

PURPOSE: The temporal series of molecular events that occur in dying retinal ganglion cells is poorly understood. We have examined the change in expression of a normally-expressed ganglion cell marker gene, Thy1, relative to the kinetics of cell loss caused by acute and chronic damaging stimuli.
METHODS: For acute experiments, mice were subjected to optic nerve crush or intravitreal injections of N-methyl-D-aspartate (NMDA) to induce ganglion cell death. RNase protection analysis was used to quantify Thy1 mRNA levels from total retina RNA and in situ hybridization was used to monitor the pattern of Thy1 positive cells. Changes in Thy1 expression were compared to the time course of cell loss induced by each treatment. To induce elevated intraocular pressure (IOP), the episcleral veins of rats were injected with hypertonic saline, which scleroses Schlemm's Canal and the trabecular meshwork. Elevated IOP was monitored every day for 35 days after which the animals were sacrificed and the retinas harvested for quantitative RT-PCR or fixed for in situ hybridization studies. Evaluation of glaucomatous damage caused by elevated IOP was determined from histological sections of the optic nerves of all rat eyes.
RESULTS: After optic nerve crush, Thy1 mRNA levels decreased within 24 h, although the number of expressing cells did not decline until 7 days. Both measures showed a loss of Thy1 well in advance of cell loss, which was detected by 2 weeks after surgery. This change in expression was not dependent on execution of the cell death program since a similar decrease was detected in Bax-/- ganglion cells, which are resistant to cell death induced by optic nerve crush. Thy1 mRNA levels and the number of expressing cells also decreased within 6 h after NMDA injection, in advance of cell loss, which was detected by 24 h. Similarly, elevated intraocular pressure was associated with a decrease in mRNA and expressing cells in a pressure-dependent manner. In moderately hypertensive rat eyes, the number of cells expressing Thy1 decreased before significant cell loss in the retina. Virtually no Thy1-expressing cells were detected in eyes with severe disease.
CONCLUSIONS: Thy1 mRNA abundance and expressing cells, decreased in advance of detectable ganglion cell loss caused by three different modalities of damage. This change is independent of the committed step of cell death.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11509915

Source DB:  PubMed          Journal:  Mol Vis        ISSN: 1090-0535            Impact factor:   2.367


  76 in total

1.  Programmed cell death-1 is expressed in large retinal ganglion cells and is upregulated after optic nerve crush.

Authors:  Wei Wang; Ann Chan; Yu Qin; Jacky M K Kwong; Joseph Caprioli; Ralph Levinson; Ling Chen; Lynn K Gordon
Journal:  Exp Eye Res       Date:  2015-08-13       Impact factor: 3.467

2.  Thy1 associates with the cation channel subunit HCN4 in adult rat retina.

Authors:  Gloria J Partida; Tyler W Stradleigh; Genki Ogata; Iv Godzdanker; Andrew T Ishida
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-03-26       Impact factor: 4.799

Review 3.  Roles and regulation of Thy-1, a context-dependent modulator of cell phenotype.

Authors:  John E Bradley; Gustavo Ramirez; James S Hagood
Journal:  Biofactors       Date:  2009 May-Jun       Impact factor: 6.113

4.  The cell and molecular biology of glaucoma: mechanisms of retinal ganglion cell death.

Authors:  Robert W Nickells
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-05-04       Impact factor: 4.799

5.  Retinal cell responses to elevated intraocular pressure: a gene array comparison between the whole retina and retinal ganglion cell layer.

Authors:  Ying Guo; William O Cepurna; Jennifer A Dyck; Tom A Doser; Elaine C Johnson; John C Morrison
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-01-13       Impact factor: 4.799

6.  Longitudinal profile of retinal ganglion cell damage after optic nerve crush with blue-light confocal scanning laser ophthalmoscopy.

Authors:  Christopher Kai-shun Leung; James D Lindsey; Jonathan G Crowston; Chen Lijia; Sylvia Chiang; Robert N Weinreb
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-04-25       Impact factor: 4.799

7.  Neurotrophic effect of a novel TrkB agonist on retinal ganglion cells.

Authors:  Ying Hu; Seongeun Cho; Jeffrey L Goldberg
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-10-29       Impact factor: 4.799

8.  Targeting HDAC3 Activity with RGFP966 Protects Against Retinal Ganglion Cell Nuclear Atrophy and Apoptosis After Optic Nerve Injury.

Authors:  Heather M Schmitt; Cassandra L Schlamp; Robert W Nickells
Journal:  J Ocul Pharmacol Ther       Date:  2017-12-06       Impact factor: 2.671

9.  Insertion of the beta Geo promoter trap into the Fem1c gene of ROSA3 mice.

Authors:  Cassandra L Schlamp; Andrew T Thliveris; Yan Li; Louis P Kohl; Claudia Knop; Joel A Dietz; Inna V Larsen; Pascal Imesch; Lawrence H Pinto; Robert W Nickells
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

10.  Nuclear atrophy of retinal ganglion cells precedes the bax-dependent stage of apoptosis.

Authors:  Katherine T Janssen; Caitlin E Mac Nair; Joel A Dietz; Cassandra L Schlamp; Robert W Nickells
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-03-11       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.